Absence of the TP53 Poly-A signal sequence variant rs78378222 in oral, cervical and breast cancers in South India

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 21, 2014, Pages 9555-9556

  Deva Magendhra Rao, Arunagiri Kuha ^a   Vinothkumar, Vilvanathan ^a   Revathidevi, Sundaramoorthy ^a   Arunkumar, Ganesan ^a   Manikandan, Mayakannan ^a   Arun, Kanagaraj ^a   Rajkumar, Kottayasamy Seenivasagam ^b   Ramani, Rajendran ^c   Ramamurthy, Rajaraman ^b   Munirajan, Arasambattu Kannan ^a  

^a UNIVERSITY OF MADRAS   (India)

^b Kilpauk Medical College   (India)

^c Chennai Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

POLYADENYLIC ACID; PROTEIN P53; SIGNAL PEPTIDE; TP53 PROTEIN, HUMAN;

BREAST TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; INDIA; MOUTH TUMOR; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX TUMOR;

BREAST NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MOUTH NEOPLASMS; POLY A; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN SORTING SIGNALS; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 84918585214     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.21.9555     Document Type: Letter

References (6)

1. Egan KM, Nabors LB, Olson JJ, et al (2012). Rare TP53 genetic variant associated with glioma risk and outcome. J Med Genet, 49, 420-1.
2. Enciso-Mora V, Hosking FJ, Di Stefano AL, et al (2013). Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br J Cancer, 108, 2178-85.
3. Guan X, Wansg LE, Liu Z, et al (2013). Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites. J Cell Mol Med, 17, 873-8.
4. Li Y, Gordon MW, Xu-Monette ZY, et al (2013). Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood, 121, 4529-40.
5. Stacey SN, Sulem P, Jonasdottir A, et al (2011). A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet, 43, 1098-103.
6. Zhou L, Yuan Q, Yang M (2012). A functional germline variant in the P53 polyadenylation signal and risk of esophageal squamous cell carcinoma. Gene, 506, 295-7.